Kymera Therapeutics (KYMR) Depreciation & Amortization (CF) (2019 - 2026)
Kymera Therapeutics (KYMR) posted Depreciation & Amortization (CF) of $2.03 million for Q2 2026, down 2.6% from $2.08 million a year earlier but up 0.4% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Kymera Therapeutics was $8.23 million, up 1.6% year-over-year; for FY2025, it came in at $8.31 million, up 12.7% from FY2024.
- Annual Depreciation & Amortization (CF) has increased for six consecutive years, with a five-year compound annual growth rate of 36.4% (FY2020 to FY2025).
- In prior years, Kymera Therapeutics' Depreciation & Amortization (CF) was $7.37 million in FY2024 (+106.8%), $3.57 million in FY2023 (+19.8%), $2.98 million in FY2022 (+24.2%) and $2.4 million in FY2021 (+36.0%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $671,000 in Q3 2021 to a high of $2.15 million in Q3 2025 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 37.4%.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2024, with growth of 123.0%; the weakest was Q2 2026, with a decline of 2.6%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $2.02 million (Q1 2026), $2.03 million (Q4 2025) and $2.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 2.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.02 Mn |
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | 895,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 879,000.00 |
| Dec 31, 2022 | 818,000.00 |
| Sep 30, 2022 | 767,000.00 |
| Jun 30, 2022 | 705,000.00 |
| Mar 31, 2022 | 687,000.00 |
| Dec 31, 2021 | 689,000.00 |
API Access
Kymera Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();